Abstract
Opiod pharmacotheraphy can provide the stability necessary to initiate lifestyle changes, obtain steady employment and function in society. Thus, a critical question is the extent to which pharmacotherapy is associated with impairment in psychomotor and cognitive performance that might affect functioning. In this article, I review human laboratory studies of the effects of the most common opioid pharmacotherapies, methadone and buprenorphine, on psychomotor and cognitive performance (both observational group comparison and experimental drug administration studies) and the effects of withdrawal from opioid pharmacotherapy on performance. I then outline some recommendations for further study in this area.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5-24 |
| Number of pages | 20 |
| Journal | Heroin Addiction and Related Clinical Problems |
| Volume | 9 |
| Issue number | 1 |
| State | Published - Mar 2007 |
| Externally published | Yes |
Keywords
- Buprenorphine
- Cognitive performance
- Methadone
- Opioid pharmacotherapy
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health